je.st
news
Tag: sanofis
Sanofi's big new cholesterol drug wins European green light
2015-07-25 13:43:00| Biotech - Topix.net
A new type of cholesterol drug from Sanofi and Regeneron Pharmaceuticals won a green light from European regulators on Friday, two months behind a rival product from Amgen. The European Medicines Agency said its experts had recommended Praluent for patients unable to control their cholesterol despite taking optimal doses of conventional statin pills or those who cannot take statins.
MannKind's Afrezza Remains in Sanofi's Plans, RBC Says
2014-11-22 19:25:26| Biotech - Topix.net
Yesterday, Sanofi hosted a seminar on new medicines in Cambridge, Mass., and RBC's Adnan Butt and team note that MannKind's inhaled insulin Afrezza "featured prominently enough." They summarize the highlights of the presentation: MannKind's partner reiterated prior guidance that a commercial launch is planned for 1Q:15.
Aastrom Biosciences Acquires Sanofi's Cell Therapy and Regenerative Medicine Business
2014-04-21 22:59:52| Biotech - Topix.net
Aastrom Biosciences , a developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, reported that it has entered into an agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine business for $6.5 million, with $4 million payable in cash at closing and $2.5 million payable ... (more)
Tags: business
cell
medicine
therapy
U.S. regulators reject Sanofi's MS treatment Lemtrada
2014-01-01 22:27:11| Biotech - Topix.net
Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme.
Tags: treatment
reject
regulators
sanofis
Sites : [1] [2]